263 related articles for article (PubMed ID: 30067938)
21. Medical comorbidities in children and adolescents with autism spectrum disorders and attention deficit hyperactivity disorders: a systematic review.
Muskens JB; Velders FP; Staal WG
Eur Child Adolesc Psychiatry; 2017 Sep; 26(9):1093-1103. PubMed ID: 28674760
[TBL] [Abstract][Full Text] [Related]
22. Associations between neurodevelopmental disorders and factors related to school, health, and social interaction in schoolchildren: Results from a Swedish population-based survey.
Beckman L; Janson S; von Kobyletzki L
Disabil Health J; 2016 Oct; 9(4):663-72. PubMed ID: 27343047
[TBL] [Abstract][Full Text] [Related]
23. Effect of co-twin gender on neurodevelopmental symptoms: a twin register study.
Eriksson JM; Lundström S; Lichtenstein P; Bejerot S; Eriksson E
Mol Autism; 2016; 7():8. PubMed ID: 26793297
[TBL] [Abstract][Full Text] [Related]
24. [Epigenetics of schizophrenia: a review].
Rivollier F; Lotersztajn L; Chaumette B; Krebs MO; Kebir O
Encephale; 2014 Oct; 40(5):380-6. PubMed ID: 25127897
[TBL] [Abstract][Full Text] [Related]
25. Risk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity disorder and their first-degree relatives: a protocol for a systematic review and meta-analysis of observational studies.
Catalá-López F; Hutton B; Page MJ; Ridao M; Driver JA; Alonso-Arroyo A; Forés-Martos J; Macías Saint-Gerons D; Vieta E; Valencia A; Tabarés-Seisdedos R
Syst Rev; 2017 Sep; 6(1):189. PubMed ID: 28915839
[TBL] [Abstract][Full Text] [Related]
26. A critical review of developmental exposure to particulate matter, autism spectrum disorder, and attention deficit hyperactivity disorder.
Fordyce TA; Leonhard MJ; Chang ET
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2018 Jan; 53(2):174-204. PubMed ID: 29157090
[TBL] [Abstract][Full Text] [Related]
27. Neurodevelopmental disorders in young violent offenders: Overlap and background characteristics.
Billstedt E; Anckarsäter H; Wallinius M; Hofvander B
Psychiatry Res; 2017 Jun; 252():234-241. PubMed ID: 28285251
[TBL] [Abstract][Full Text] [Related]
28. [Attention deficit hyperactivity disorder: from a neurodevelopmental perspective].
Fernandez-Jaen A; Lopez-Martin S; Albert J; Martin Fernandez-Mayoralas D; Fernandez-Perrone AL; Calleja-Perez B; Lopez-Arribas S
Rev Neurol; 2017 Feb; 64(s01):S101-S104. PubMed ID: 28256695
[TBL] [Abstract][Full Text] [Related]
29. Progress and roadblocks in the search for brain-based biomarkers of autism and attention-deficit/hyperactivity disorder.
Uddin LQ; Dajani DR; Voorhies W; Bednarz H; Kana RK
Transl Psychiatry; 2017 Aug; 7(8):e1218. PubMed ID: 28892073
[TBL] [Abstract][Full Text] [Related]
30. Neurodevelopmental Disorders and Environmental Toxicants: Epigenetics as an Underlying Mechanism.
Tran NQV; Miyake K
Int J Genomics; 2017; 2017():7526592. PubMed ID: 28567415
[TBL] [Abstract][Full Text] [Related]
31. Epigenomic Convergence of Neural-Immune Risk Factors in Neurodevelopmental Disorder Cortex.
Vogel Ciernia A; Laufer BI; Hwang H; Dunaway KW; Mordaunt CE; Coulson RL; Yasui DH; LaSalle JM
Cereb Cortex; 2020 Mar; 30(2):640-655. PubMed ID: 31240313
[TBL] [Abstract][Full Text] [Related]
32. Epigenetics as a basis for diagnosis of neurodevelopmental disorders: challenges and opportunities.
Kubota T; Miyake K; Hariya N; Mochizuki K
Expert Rev Mol Diagn; 2014 Jul; 14(6):685-97. PubMed ID: 24902600
[TBL] [Abstract][Full Text] [Related]
33. Neurodevelopmental Disorders (ASD and ADHD): DSM-5, ICD-10, and ICD-11.
Doernberg E; Hollander E
CNS Spectr; 2016 Aug; 21(4):295-9. PubMed ID: 27364515
[TBL] [Abstract][Full Text] [Related]
34. Paternal Aging Affects Behavior in Pax6 Mutant Mice: A Gene/Environment Interaction in Understanding Neurodevelopmental Disorders.
Yoshizaki K; Furuse T; Kimura R; Tucci V; Kaneda H; Wakana S; Osumi N
PLoS One; 2016; 11(11):e0166665. PubMed ID: 27855195
[TBL] [Abstract][Full Text] [Related]
35. The Role of Epigenetics in the Pathogenesis and Potential Treatment of Attention Deficit Hyperactivity Disorder.
Peedicayil J
Curr Neuropharmacol; 2022 Aug; 20(9):1642-1650. PubMed ID: 34544344
[TBL] [Abstract][Full Text] [Related]
36. Risk of Neurodevelopmental Disease by Paternal Aging: A Possible Influence of Epigenetic Alteration in Sperm.
Kimura R; Yoshizaki K; Osumi N
Adv Exp Med Biol; 2018; 1012():75-81. PubMed ID: 29956196
[TBL] [Abstract][Full Text] [Related]
37. Shared Brain Connectivity Issues, Symptoms, and Comorbidities in Autism Spectrum Disorder, Attention Deficit/Hyperactivity Disorder, and Tourette Syndrome.
Kern JK; Geier DA; King PG; Sykes LK; Mehta JA; Geier MR
Brain Connect; 2015 Aug; 5(6):321-35. PubMed ID: 25602622
[TBL] [Abstract][Full Text] [Related]
38. Cannabis Exposure During Critical Windows of Development: Epigenetic and Molecular Pathways Implicated in Neuropsychiatric Disease.
Smith A; Kaufman F; Sandy MS; Cardenas A
Curr Environ Health Rep; 2020 Sep; 7(3):325-342. PubMed ID: 32441004
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity of executive functions among comorbid neurodevelopmental disorders.
Dajani DR; Llabre MM; Nebel MB; Mostofsky SH; Uddin LQ
Sci Rep; 2016 Nov; 6():36566. PubMed ID: 27827406
[TBL] [Abstract][Full Text] [Related]
40. Epigenetics of Autism Spectrum Disorder.
Siu MT; Weksberg R
Adv Exp Med Biol; 2017; 978():63-90. PubMed ID: 28523541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
